FindTrial
Sign In

Effect of PRM-125 on Ambulatory Blood Pressure

Evaluation of Once-Daily PRM125 On Ambulatory Blood Pressure in Adults With Hypertension

Status
Withdrawn
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05195827
Enrollment
0
Registered
2022-01-19
Start date
2021-12-20
Completion date
2022-11-30
Last updated
2023-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Brief summary

Evaluation of Once-Daily PRM125 On Ambulatory Blood Pressure in Adults with Hypertension

Detailed description

Approximately 60 subjects with primary hypertension are treated for 8 weeks with PRM125 to determine if Ambulatory Blood Pressure is changed.

Interventions

DRUGPRM-125

Antihypertensive

Sponsors

PRM Pharma, LLC
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
30 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* primary hypertension

Exclusion criteria

* medical conditions that preclude evaluation and/or adversely effect subject safety

Design outcomes

Primary

MeasureTime frame
Change in 24 hour Systolic Blood Pressure8 weeks

Secondary

MeasureTime frame
Change in 24 hour Diastolic Blood Pressure8 weeks

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026